Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles Lee Nuzum Sr currently holds 20,388 shares of Predictive Oncology Inc. (POAI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Lee Nuzum Sr has been a net buyer of POAI stock. They have purchased $62.0K and sold $30.4K worth of shares.
Charles Lee Nuzum Sr's most recent insider trade was on Apr 20, 2026, when they sold 14,082 shares at $0.00 per share.
Charles Lee Nuzum Sr serves as Executive at Predictive Oncology Inc. (POAI). They have executed 18 insider transactions totaling $92.4K over their tenure at the company.
Charles Lee Nuzum Sr holds the position of Executive at Predictive Oncology Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Charles Lee Nuzum Sr has shown a buying trading pattern, with $62.0K in total purchases and $30.4K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Charles Lee Nuzum Sr was on May 20, 2022, when they purchased $62.0K worth of POAI shares. This transaction involved 200,000 shares at $0.31 per share.
Charles Lee Nuzum Sr currently owns 20,388 shares of Predictive Oncology Inc. (POAI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles Lee Nuzum Sr's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles Lee Nuzum Sr has 18 Form 4 filings on record as an insider at Predictive Oncology Inc..
Set alerts for Charles Lee Nuzum Sr and 40,000+ other insiders.